HBB and Alzheimer disease: Low baseline CSF HPX levels were observed in MCI individuals who are CSF biomarker-positive, concomitant with elevated levels of CSF Hbα and Hbβ subunits, which would contribute to inefficient HPX scavenging of heme in AD pathogenesis.